Invention Grant
US09534051B2 Immunoregulation by anti-ILT5 antibodies and ILT5-binding antibody fragments
有权
抗ILT5抗体和ILT5结合抗体片段的免疫调节
- Patent Title: Immunoregulation by anti-ILT5 antibodies and ILT5-binding antibody fragments
- Patent Title (中): 抗ILT5抗体和ILT5结合抗体片段的免疫调节
-
Application No.: US14462596Application Date: 2014-08-19
-
Publication No.: US09534051B2Publication Date: 2017-01-03
- Inventor: Irina Apostolou , Paul Ponath , Joe Ponte , Michael Rosenzweig , Lou Vaickus
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K35/00 ; A61K35/15 ; A61K39/00
Abstract:
Disclosed herein are methods of using anti-ILT5 antibodies and ILT5-binding fragments thereof for the treatment of various diseases and for use as immunostimulatory adjuvants.
Public/Granted literature
- US20150010564A1 IMMUNOREGULATION BY ANTI-ILT5 ANTIBODIES AND ILT5-BINDING ANTIBODY FRAGMENTS Public/Granted day:2015-01-08
Information query
